I disagree with CMS's coverage decision to tightly restrict coverage for an entire class of FDA-approved Alzheimer's drugs.
Nanette Barragán: “I disagree with CMS's coverage decision to tightly restrict coverage for an entire class of FDA-approved Alzheimer's…”
On the recordMarch 28, 2023
Source
congress.govEditor's note · Context
Barragan criticizes CMS for restricting coverage of approved Alzheimer's drugs.
Share
More from Nanette Barragán
Apr 17, 2023
It's important for the committee to provide oversight and get answers to ensure the Corps implements the Water Resources Development Act of 2020 in line with Congressional intent.
Oct 3, 2026
Americans work hard to feed their families. As Trump and Republicans continue to skyrocket the cost of food and other basic necessities, businesses need to keep their prices transparent and fair.
Jul 29, 2025
If Texas is going to rig the system, then I think we can’t just sit back and watch it and do nothing and say we’re going to have our hands tied.
Jun 7, 2025
This is an abuse of power and what dictators do. It's unnecessary and not needed.





